Social Analytics Toolkit – Gilead
Project Overview
Boston University is supporting Gilead’s Global Patient Solutions (GPS) business unit in developing internal capacity in monitoring and evaluation of their access program efforts.
Internal capacity in monitoring and evaluation is necessary for pharmaceutical companies to ensure learning, continuous improvement, and to document and communicate contributions of their access programs.
GPS’s focus is to enable patient access to life-saving medicines through innovation and sustainable partnerships, spanning 130 resource-limited, low, lower-middle and upper-middle income countries across Latin America, Africa, Eastern Europe and Asia. The unit plans to strengthen program reporting and submission of data to the Access to Medicines (ATM) Index.
This project will provide Gilead with social analytic tools, which facilitate public reporting on company access programs. Social Analytics are a set of tools and methods for understanding and measuring social aspects of private industry-led programs. They facilitate innovation processes by providing timely information on key aspects of program performance.
The Sustainable Development Goals (SDGs), specifically SGD 17, recognize the specific responsibility of the private sector in contributing to global social aims. The pharmaceutical industry has a special role to play in contributing to the SDGs because their products have a direct impact on the health and well-being of populations. Part of this responsibility involves documenting their contributions in a methodologically sound and transparent manner.
Key activities
-
- Build internal capacity in monitoring and evaluation within GPS
- Conduct virtual M&E training sessions
- Conduct in-person training sessions
- Identify lessons learned and strengthen measurement and reporting on the HCV elimination program
- Conduct literature review of HCV elimination programs
Conduct a review of Gilead program documents
- Conduct literature review of HCV elimination programs
- Develop or refine selected program’s ToC, metrics and measurement plan for selected programs
- Revise program logic model
- Generate an initial list of suggested metrics
- Refine the list to a set that can feasibly be collected in each program
- Disseminate key learnings to external audiences
- Build internal capacity in monitoring and evaluation within GPS
Agreement
Master Service Agreement signed by Boston University forthcoming.
Related Resources
This project is part of broader effort by Boston University faculty to improve measurement and reporting for pharmaceutical industry-led access programs. This effort includes:
- The Access Observatory (accessobservatory.org), a public reporting platform for industry-led access programs.
- A review of strategies and evidence on the impact of industry-led access programs, published in Health Affairs (link)
- A commentary on the unique opportunity currently available for industry, academia, and global health stakeholders to come together to strengthen institutions for measuring industry-led access programs (link)